Engineering tough blood clots for rapid haemostasis and enhanced regeneration

Engineered blood clots using rapidly crosslinked red blood cells form within seconds, significantly improving toughness and adhesion while effectively stopping bleeding and promoting tissue repair. The study, published in Nature, highlights a breakthrough in haemostasis and regeneration.